SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Fresenius Medical Care AG & Co. KGAA

Recent community interest in Fresenius Medical Care (FMS) stems from potential applications of DefenCath in dialysis and discussions around mortality benefits and infection prevention, particularly in comparison to competitors. Discussions also highlight an upcoming earnings report and its growth potential, with some suggesting it's undervalued, while others point to rising costs pressuring near-term results. Acquisition and partnership strategies are seemingly driving growth, but regulatory concerns persist in the dialysis and healthcare services sector.

SSgA Active Trust - The Energy Select Sector SPDR Fund

Energy Select Sector SPDR Fund

The energy sector, represented by $XLE, is experiencing heightened volatility amidst geopolitical tensions and speculation around OPEC+ production decisions. Community discussions center on the potential for both short squeezes and longer-term gains, weighing factors like global demand, supply disruptions, and the impact of tariffs on the energy market. Traders are actively monitoring technical indicators and news events for directional cues, with some highlighting a possible rotation into energy amid broader market uncertainty.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending due to positive momentum, fueled by strong revenue growth and optimism surrounding upcoming earnings, with the community discussing potential price targets and buyout scenarios. Community members are highlighting the company's solid fundamentals and pipeline, particularly Recorlev, while anticipating positive EPS. Bullish sentiment is driven by high growth expectations and potential upside from the XP-8121 program.

Internet Computer (IC) is the world’s first blockchain that is capable of running at web speed at unrestrictive capacities. Built by the DFINITY Foundation, IC aims to recreate the web by supporting smart contract development at scale and changing the way people can interact using web services. Internet Computer aims to extend the public internet, so that it can be the world’s computing platform, in a decentralized manner. Internet Computer sets to revolutionalize the design of the crypto economy, with an aim to overhaul traditional software services.   The project was founded in October 2016 by Dominic WIllams and have raised a total of $121 million from investors such as Adreessen Horowitz, Polychain Capital, Multicoin Capital and such. On May 10, 2021, DFINITY launched the Internet Computer into the public domain, marking it a major milestone for ICP as it means the internet now functions as a decentralised global computer. This is marked by the release of all of the Internet Computer’s source code into the public domain, as well as ICP utility token that allows tens of thousands of community members to govern the Internet Computer network.  ICP is Internet Computer's native token. It plays three prominent roles:  1. Network Governance: Users that participate in the governance will be rewarded with ICPI 2. Production of Cycles for Compute: ICP can be converted into cycles where it is used as the transaction fee to access the network. Cycles are burned after used. 3. Rewarding Users: ICP is used as the rewards to incentivize users to participate in the network such as securing the network.

Internet Computer

Internet Computer (ICP) is trending amid discussions about its potential as a decentralized alternative to cloud providers like Amazon and Google.  The community is analyzing a recent price pump, questioning its sustainability and potential catalysts, while also debating the impact of fully unlocked tokens and the launch of Caffeine AI. Some believe ICP is poised for significant growth due to its technology and increasing trading volume, while others remain skeptical, citing past performance and tokenomics.

VanEck ETF Trust - VanEck Rare Earth/Strategic Metals ETF

VanEck Rare Earth and Strategic Metals ETF

REMX is trending due to increased investor interest in rare earth metals, fueled by discussions around supply chain vulnerabilities and geopolitical tensions, particularly those involving China. Community members are evaluating the ETF's composition and debating its potential amidst evolving trade dynamics and resource nationalism. There's also discussion of its strong chart and potential for further upside amid rising demand in EVs and clean energy technologies.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve is trending amid anticipation for potential cannabis rescheduling, spurred by comments from President Trump regarding a decision in the coming weeks. Community discussions revolve around the potential for significant gains, the impact on MSOs, and comparisons to Canadian LPs, while some caution against over-optimism. A potential Florida recreational vote in 2026 is also a key talking point for long term growth.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

JMIA is trending as investors react to a recent analyst upgrade with a significantly increased price target. Community members are actively discussing the potential for further gains, citing upcoming earnings and an investor day as potential catalysts. Some are pointing to technical indicators like cup-and-handle formations, while others highlight Jumia's strategic position in the African e-commerce market.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is trending due to a mix of factors, including potential tariff relief and a UBS upgrade citing margin optimism. The community is actively discussing GM's EV strategy, sales performance, and potential impact from government policies. Some are questioning if the recent positive price action is sustainable, while others highlight the stock's attractive valuation relative to peers.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is trending as investors assess if the semiconductor rally can continue, with some analysts pointing to overbought conditions and potential for a correction. Community members are debating the impact of AI spending, the potential for a chip glut, and revenue projections for chip manufacturers. Bullish sentiment remains due to the AI buildout, while others warn of bubble-like conditions reminiscent of the dot-com era.

What makes MOG an absolute game-changer is our relentless dedication to memes and viral brilliance! We don't settle for mediocrity; we plunge into the realm of sheer awesomeness! Our community is a powerhouse of meme warriors, unleashing an unstoppable onslaught of viral memes that'll leave you in awe and stitches!  We're not here to play games; we're here to dominate! MOG is all about pushing the boundaries, smashing through barriers, and leaving our competitors eating our dust! Our passion for humor burns like an inferno, and we won't rest until the entire internet bows down to our meme supremacy!  And our community? It's a brotherhood, an unyielding powerhouse of support and camaraderie! When you're part of MOG, you're part of an unstoppable force, a family forged by the fire of meme revolution!  So, if you're ready to be part of the most intense, mind-bending memecoin movement ever conceived, then buckle up, strap in, and brace yourself! MOG is here to claim the throne, and we're taking no prisoners! Get ready to witness meme history in the making!

 MOG Coin

MOG Coin is trending as traders discuss recent price pumps and dips, with some anticipating a significant run-up and others labeling it a scam. Community members are actively debating entry and exit points, with some expressing frustration over scalpers. The coin's potential listing on major exchanges like Robinhood and Binance is a recurring topic.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arcutis Biotherapeutics, Inc. (ARQT) Hits Fresh High: Is There Still Room to Run?

Arcutis Biotherapeutics (ARQT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

What Makes Arcutis Biotherapeutics (ARQT) a New Strong Buy Stock

Arcutis Biotherapeutics (ARQT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Is Grifols (GRFS) Stock Outpacing Its Medical Peers This Year?

Here is how Grifols (GRFS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Arcutis Biotherapeutics, Inc. (ARQT) Q3 Earnings and Revenues Surpass Estimates

Arcutis Biotherapeutics (ARQT) delivered earnings and revenue surprises of +160.00% and +14.87%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Arcutis Biotherapeutics, Inc. (ARQT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Arcutis Biotherapeutics (ARQT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Tarsus Pharmaceuticals (TARS) Moves 10.9% Higher: Will This Strength Last?

Tarsus Pharmaceuticals (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Arcutis Biotherapeutics, Inc. (ARQT) Hit a 52 Week High, Can the Run Continue?

Are Medical Stocks Lagging  Arcutis Biotherapeutics (ARQT) This Year?

Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Here's Why Arcutis Biotherapeutics, Inc. (ARQT) is a Great Momentum Stock to Buy

Does Arcutis Biotherapeutics, Inc. (ARQT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are Medical Stocks Lagging  AxoGen (AXGN) This Year?

Here is how AxoGen (AXGN) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Arcutis Biotherapeutics Inc

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

ARQT
Arcutis Biotherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARQT News

ARQTArcutis Biotherapeutics Inc